| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $171.2M | — | +0.4% |
| Cost of Revenue | $100.8M | — | +18.3% |
| Gross Profit | $70.3M | — | -17.5% |
| R&D Expense | $26.7M | — | +33.0% |
| SG&A Expense | $18.0M | — | +12.7% |
| Operating Income | $13.6M | — | -63.5% |
| Pre-tax Income | $10.1M | — | -67.4% |
| Income Tax | $3.6M | — | -34.9% |
| Net Income | $6.4M | — | -74.6% |
| EPS (Basic) | $0.14 | — | -73.6% |
| EPS (Diluted) | $0.14 | — | -72.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $170.9M | +0.4% | -6.5% |
| Short-term Investments | $121.0M | +7.4% | +123.7% |
| Accounts Receivable | $147.8M | +3.0% | +2.2% |
| Inventory | $170.2M | -3.8% | -8.2% |
| Current Assets | $633.7M | -0.4% | +7.8% |
| Total Assets | $1.65B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $47.8M | — | +36.4% |
| Capital Expenditures | $9.5M | — | -11.1% |
| Investing Cash Flow | -$16.7M | — | -259.7% |
| Financing Cash Flow | -$30.2M | — | -108.3% |
| Free Cash Flow | $38.3M | — | +57.2% |
| +1.3% |
| Current Liabilities | $164.5M | +4.0% | -17.4% |
| Long-term Debt | $609.8M | -1.6% | +1.0% |
| Total Liabilities | $874.8M | +4.1% | -0.0% |
| Stockholders' Equity | $773.4M | -2.0% | +2.9% |